Genprex, Inc. Gains 64.35%

Wed, Jan 22, 2020 at 05:30 PM
Genprex, Inc. Gains 64.35%

Genprex, Inc. (GNPX:NASDAQ) soared at $1.89, representing a gain of 64.3%. On Tue 21 Jan 20, GNPX:NASDAQ hit a New 2-Week High of $1.15. The stock appeared on our News Catalysts scanner on Wed 22 Jan 20 at 12:01 PM in the 'BIOTECH' category. From Mon 30 Dec 19, the stock recorded 42.86% Up Days and 26.67% Green Days

The stock spiked on Tue 21 Jan 20 at $1.74 with a volume of 53M+.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.